Growth factor independent 1B is a metabolic regulator that exerts pleiotropic effects on platelet function
Journal of Thrombosis and Haemostasis · 2025
DOI: 10.1016/j.jtha.2025.06.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Marie-Christine Morel-Kopp und 17 weiteren Autor:innen. Beteiligte Einrichtung: Northern Blood Research Centre, Kolling Institute, The University of Sydney, Sydney, New South Wales, Australia; Department of Haematology and Transf…. Hauptthemen laut MEDLINE: Blood Platelets, Megakaryocytes, Thrombocytopenia, Hemorrhage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Walter and Eliza Hall Institute.
Abstract (Originalsprache)
BACKGROUND: Human variants in the growth factor independent 1B (GFI1B) transcription factor are associated with thrombocytopenia and a variable bleeding phenotype. OBJECTIVES: In this study, we examined the bleeding phenotype associated with the human GFI1BH294fs variant and compared it with a mouse model of abnormal GFI1B function. METHODS: The transcriptomic and proteomic profiles of human GFI1BH294fs platelets were analyzed and compared with those of murine megakaryocytes harboring conditional deletion of Gfi1b. Observed changes were subsequently validated with imaging and western blotting and in a cell model of endocytosis. RESULTS: All individuals with the GFI1BH294fs variant displayed markedly impaired or absent platelet aggregation responses to collagen stimulation as assessed by light transmission aggregometry. Mice with conditional deletion of Gfi1b in the megakaryocyte lineage had severe thrombocytopenia with increased numbers of abnormal megakaryocytes and progenitors. Proteomic pathway analysis of human platelets and mouse megakaryocytes revealed defects in platelet aggregation and spreading, dysregulated glycoprotein VI and integrin signaling, and reduced endocytosis. Megakaryocytes deficient in Gfi1b displayed structural abnormalities and endocytosis failure with decreased fibrinogen uptake from surrounding media consistent with the fibrinogen deficiency observed in human GFI1BH294fs platelets. Unexpectedly, oxidative phosphorylation was upregulated in both platelets and megakaryocytes, and this was associated with mitochondrial hyperplasia on cell imaging. Pyruvate kinase M2 emerged as a potential mediator of these metabolic changes. CONCLUSION: Dysregulated GFI1B function affects multiple biological pathways linked to abnormal bleeding. Reduced GFI1B activity also induces metabolic reprogramming in platelets and megakaryocytes, leading to enhanced oxidative phosphorylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Northern Blood Research Centre, Kolling Institute, The University of Sydney, Sydney, New South Wales, Australia; Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, New South Wales, A…
- Northern Blood Research Centre, Kolling Institute, The University of Sydney, Sydney, New South Wales, Australia.
- Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.
- Bowel Cancer and Biomarker Laboratory, Kolling Institute, School of Medical Sciences, The University of Sydney, Sydney, New South Wales, Australia.
- Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
- Platelet and Thrombosis Research Group, Australian and New Zealand Army Corps Research Institute, Sydney Local Health District, University of Sydney, Sydney, New South Wales, Australia; Department of Haematology, Concor…
Förderung
- Walter and Eliza Hall Institute
Zitieren
APA
Morel-Kopp, M. C., Levade, M., Beutler, L., Chen, Q., Othman, J., Steffen, P., McKay, M. J., Molloy, M. P., Selvadurai, M. V., Liang, H. P. H., Whittaker, S., van der Wal, D. E., Gabrielli, S., Hamilton, J. R., Chen, V. M., Ng, A. P., Ward, C. M., & Stevenson, W. S. (2025). Growth factor independent 1B is a metabolic regulator that exerts pleiotropic effects on platelet function. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.06.021
Vancouver
Morel-Kopp MC, Levade M, Beutler L, Chen Q, Othman J, Steffen P, et al. Growth factor independent 1B is a metabolic regulator that exerts pleiotropic effects on platelet function. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.06.021
BibTeX
@article{MorelKopp2025,
author = {Morel-Kopp, Marie-Christine and Levade, Marie and Beutler, Lucinda and Chen, Qiang and Othman, Jad and Steffen, Pascal and McKay, Matthew J and Molloy, Mark P and Selvadurai, Maria V and Liang, Helena P H and Whittaker, Shane and van der Wal, Dianne E and Gabrielli, Sara and Hamilton, Justin R and Chen, Vivien M and Ng, Ashley P and Ward, Christopher M and Stevenson, William S},
title = {Growth factor independent 1B is a metabolic regulator that exerts pleiotropic effects on platelet function},
journal = {Journal of Thrombosis and Haemostasis},
year = {2025},
doi = {10.1016/j.jtha.2025.06.021}
}
EUVIMED